236 related articles for article (PubMed ID: 26002013)
1. Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database.
Duchman KR; Gao Y; Miller BJ
Cancer Epidemiol; 2015 Aug; 39(4):593-9. PubMed ID: 26002013
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for survival in patients with Ewing's sarcoma using the surveillance, epidemiology, and end results (SEER) program database.
Duchman KR; Gao Y; Miller BJ
Cancer Epidemiol; 2015 Apr; 39(2):189-95. PubMed ID: 25595632
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database.
Miller BJ; Cram P; Lynch CF; Buckwalter JA
J Bone Joint Surg Am; 2013 Jul; 95(13):e89. PubMed ID: 23824394
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
5. Adverse impact of regional lymph node involvement in osteosarcoma.
Thampi S; Matthay KK; Goldsby R; DuBois SG
Eur J Cancer; 2013 Nov; 49(16):3471-6. PubMed ID: 23867123
[TBL] [Abstract][Full Text] [Related]
6. Conditional survival is greater than overall survival at diagnosis in patients with osteosarcoma and Ewing's sarcoma.
Miller BJ; Lynch CF; Buckwalter JA
Clin Orthop Relat Res; 2013 Nov; 471(11):3398-404. PubMed ID: 23821136
[TBL] [Abstract][Full Text] [Related]
7. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
8. Rural patients are at risk for increased stage at presentation and diminished overall survival in osteosarcoma.
Wendt R; Gao Y; Miller BJ
Cancer Epidemiol; 2019 Aug; 61():119-123. PubMed ID: 31212223
[TBL] [Abstract][Full Text] [Related]
9. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
10. The Role of Chemotherapy in the Survival Benefits of Patients Aged Older Than 40 Years With Osteosarcoma.
Cao Z; Zhang Y; Xu Q; Yu X; Liu X; Dai M
Technol Cancer Res Treat; 2021; 20():15330338211066195. PubMed ID: 34918558
[No Abstract] [Full Text] [Related]
11. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database.
Giuffrida AY; Burgueno JE; Koniaris LG; Gutierrez JC; Duncan R; Scully SP
J Bone Joint Surg Am; 2009 May; 91(5):1063-72. PubMed ID: 19411454
[TBL] [Abstract][Full Text] [Related]
12. Association of extent of local tumor invasion and survival in patients with malignant primary osseous spinal neoplasms from the surveillance, epidemiology, and end results (SEER) database.
Mukherjee D; Chaichana KL; Adogwa O; Gokaslan Z; Aaronson O; Cheng JS; McGirt MJ
World Neurosurg; 2011 Dec; 76(6):580-5. PubMed ID: 22251507
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.
Song K; Song J; Lin K; Chen F; Ma X; Jiang J; Li F
Int Orthop; 2019 Aug; 43(8):1983-1991. PubMed ID: 31127366
[TBL] [Abstract][Full Text] [Related]
14. Socioeconomic measures influence survival in osteosarcoma: an analysis of the National Cancer Data Base.
Miller BJ; Gao Y; Duchman KR
Cancer Epidemiol; 2017 Aug; 49():112-117. PubMed ID: 28601784
[TBL] [Abstract][Full Text] [Related]
15. Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.
Colding-Rasmussen T; Thorn AP; Horstmann P; Rechnitzer C; Hjalgrim LL; Krarup-Hansen A; Petersen MM
Acta Oncol; 2018 Mar; 57(3):420-425. PubMed ID: 28741397
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Prognostic Factors of Patients With Osteosarcoma Older Than 60 Years From the SEER Database.
Pan Y; Chen D; Hu T; Lv G; Dai Z
Cancer Control; 2019; 26(1):1073274819888893. PubMed ID: 31773978
[TBL] [Abstract][Full Text] [Related]
17. A population-based propensity-matched study of regional dissections in patients with metastatic osteosarcoma.
Wang W; Ding H; Sun Z; Jin C; Zhu Y; Wang X
J Orthop Surg Res; 2020 Mar; 15(1):107. PubMed ID: 32169092
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes of pediatric osteosarcoma and Ewing's sarcoma: a comparison of surgery type within the SEER database, 1988-2007.
Schrager J; Patzer RE; Mink PJ; Ward KC; Goodman M
J Registry Manag; 2011; 38(3):153-61. PubMed ID: 22223058
[TBL] [Abstract][Full Text] [Related]
19. Evaluating and Predicting the Probability of Death in Patients with Non-Metastatic Osteosarcoma: A Population-Based Study.
Huang R; Xian S; Shi T; Yan P; Hu P; Yin H; Meng T; Huang Z
Med Sci Monit; 2019 Jun; 25():4675-4690. PubMed ID: 31231119
[TBL] [Abstract][Full Text] [Related]
20. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
